Man Group PLC Aldeyra Therapeutics, Inc. Transaction History

Man Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$5.77 - $9.93 $25,087 - $43,175	-4,348 Reduced 21.78%	15,619 $155,000
Q4 2022 Feb 14, 2023	BUY	$5.08 - $7.09 $101,432 - $141,566	19,967 New	19,967 $138,000
Q4 2020 Feb 16, 2021	SELL	$6.31 - $8.13 $89,602 - $115,446	-14,200 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.0 - $7.53 $56,800 - $106,926	14,200 New	14,200 $105,000

117

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $280M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.